ARTICLE SUMMARY:
After a pause in fundraising caused by the pandemic, Endeavour Vision recently closed its latest fund and has already made eight investments.
One year into the global pandemic, early concerns that the virus would all but shut down venture investing in medtech companies have proven largely unfounded. Not only do VCs continue to be active investors, but they continue to be supported by LPs as several prominent medtech VCs have announced the raise of new funds in the last year, including LSP, Gilde Healthcare, and Longitude Capital. The most recent example: Endeavour Vision.
